Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Clin Transplant. 2020 Mar;34(3):e13802. doi: 10.1111/ctr.13802. Epub 2020 Feb 20.
A number of deceased donor kidney scoring systems have been developed to predict post-transplant graft failure. However, studies comparing the predictive ability of these scoring systems to each other are lacking.
We used single-center histopathologic and UNOS data from 140 marginal deceased donor kidneys and transplant recipients to compare the predictive accuracy of the Maryland Aggregate Pathology Index (MAPI), Kidney Donor Risk Index (KDRI), Remuzzi, and Nyberg scoring systems for 2-year graft survival using time-dependent receiver operating curves and Kaplan-Meier analysis.
MAPI had the highest predictive accuracy (area under curve [AUC] = 0.81) compared to KDRI (AUC = 0.45), Remuzzi (AUC = 0.59), and Nyberg (AUC = 0.63) for 2-year graft survival. Furthermore, when analyzing each score according to its pre-defined risk strata, MAPI was the only scoring system for which 2-year graft survival was significantly different across strata (84.3% for low risk, 56.5% for intermediate risk, and 50% for high risk, P < .001). Additionally, MAPI was the only risk score significantly associated with 2-year graft survival (hazard ratio per point: 1.12, 95% confidence interval [CI]: 1.01-1.23, P = .03).
In a single-center cohort of biopsied marginal kidneys used for transplantation, MAPI had the best predictive ability of these four scoring systems. When biopsy data are available for kidneys considered for transplantation, the MAPI score may provide additional information that could be used to better identify kidneys likely to have longer graft survival.
已经开发出许多用于预测移植后移植物失败的死亡供体肾脏评分系统。然而,缺乏比较这些评分系统彼此之间预测能力的研究。
我们使用来自 140 个边缘死亡供体肾脏和移植受者的单中心组织病理学和 UNOS 数据,使用时间依赖性接收器操作曲线和 Kaplan-Meier 分析比较 Maryland Aggregate Pathology Index (MAPI)、Kidney Donor Risk Index (KDRI)、Remuzzi 和 Nyberg 评分系统对 2 年移植物存活率的预测准确性。
与 KDRI (AUC = 0.45)、Remuzzi (AUC = 0.59)和 Nyberg (AUC = 0.63)相比,MAPI 具有最高的预测准确性(曲线下面积 [AUC] = 0.81),用于 2 年移植物存活率。此外,当根据其预定义的风险分层分析每个评分时,MAPI 是唯一一个在分层中 2 年移植物存活率显著不同的评分系统(低危为 84.3%,中危为 56.5%,高危为 50%,P < 0.001)。此外,MAPI 是唯一与 2 年移植物存活率显著相关的风险评分(每点危险比:1.12,95%置信区间 [CI]:1.01-1.23,P = 0.03)。
在用于移植的活检边缘肾脏的单中心队列中,MAPI 在这四个评分系统中具有最佳的预测能力。当可获得用于移植的肾脏的活检数据时,MAPI 评分可能提供可用于更好地识别可能具有更长移植物存活率的肾脏的额外信息。